- Home
- ZTEK vs RDIB Comparison
ZTEK vs RDIB Comparison
Compare ZTEK & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTEK
- RDIB
- Stock Information
- Founded
- ZTEK 2008
- RDIB 1937
- Country
- ZTEK Canada
- RDIB United States
- Employees
- ZTEK N/A
- RDIB N/A
- Industry
- ZTEK Major Chemicals
- RDIB Movies/Entertainment
- Sector
- ZTEK Industrials
- RDIB Consumer Discretionary
- Exchange
- ZTEK Nasdaq
- RDIB Nasdaq
- Market Cap
- ZTEK 165.9M
- RDIB 140.2M
- IPO Year
- ZTEK N/A
- RDIB N/A
- Fundamental
- Price
- ZTEK $1.16
- RDIB N/A
- Analyst Decision
- ZTEK
- RDIB
- Analyst Count
- ZTEK 0
- RDIB 0
- Target Price
- ZTEK N/A
- RDIB N/A
- AVG Volume (30 Days)
- ZTEK 33.2K
- RDIB 12.1K
- Earning Date
- ZTEK 08-13-2025
- RDIB 08-13-2025
- Dividend Yield
- ZTEK N/A
- RDIB N/A
- EPS Growth
- ZTEK N/A
- RDIB N/A
- EPS
- ZTEK N/A
- RDIB N/A
- Revenue
- ZTEK $607,016.00
- RDIB $205,644,000.00
- Revenue This Year
- ZTEK N/A
- RDIB $7.47
- Revenue Next Year
- ZTEK N/A
- RDIB $13.22
- P/E Ratio
- ZTEK N/A
- RDIB N/A
- Revenue Growth
- ZTEK 2826.26
- RDIB N/A
- 52 Week Low
- ZTEK $0.50
- RDIB $5.78
- 52 Week High
- ZTEK $1.84
- RDIB $21.34
- Technical
- Relative Strength Index (RSI)
- ZTEK 30.38
- RDIB 48.95
- Support Level
- ZTEK $1.03
- RDIB $9.30
- Resistance Level
- ZTEK $1.16
- RDIB $11.25
- Average True Range (ATR)
- ZTEK 0.10
- RDIB 1.07
- MACD
- ZTEK -0.03
- RDIB -0.03
- Stochastic Oscillator
- ZTEK 17.02
- RDIB 28.64
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.